Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,265
archived clinical trials in
Crohns Disease

A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Gastroenterology Group of Naples
mi
from
Naples, FL
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Gastroenterology Group of Naples
mi
from
Naples, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Shafran Gastroenterology Center
mi
from
Winter Park, FL
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Shafran Gastroenterology Center
mi
from
Winter Park, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Gastroenterology Associates of Central Georgia
mi
from
Macon, GA
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Gastroenterology Associates of Central Georgia
mi
from
Macon, GA
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
University of Chicago Hospital Medical Center
mi
from
Chicago, IL
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
University of Chicago Hospital Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
University of Louisville School of Medicine
mi
from
Louisville, KY
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
University of Louisville School of Medicine
mi
from
Louisville, KY
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Metropolitan Gastroenterology Group, P.C.
mi
from
Chevy Chase, MD
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Metropolitan Gastroenterology Group, P.C.
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Endoscopic Microsurgery Associates
mi
from
Towson, MD
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Endoscopic Microsurgery Associates
mi
from
Towson, MD
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
MedRACS
mi
from
Quincy, MA
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
MedRACS
mi
from
Quincy, MA
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Clinical Research Institute of Michigan,
mi
from
Chesterfield, MI
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Clinical Research Institute of Michigan,
mi
from
Chesterfield, MI
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Center for Digestive Health
mi
from
Troy, MI
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Center for Digestive Health
mi
from
Troy, MI
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Digestive Health Center
mi
from
Ocean Springs, MS
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Digestive Health Center
mi
from
Ocean Springs, MS
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
St. Louis Center for Clinical Research
mi
from
St. Louis, MO
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
St. Louis Center for Clinical Research
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Long Island Clinical Research Associates, LLP
mi
from
Great Neck, NY
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Long Island Clinical Research Associates, LLP
mi
from
Great Neck, NY
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
NY Scientific CORP
mi
from
Hollis, NY
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
NY Scientific CORP
mi
from
Hollis, NY
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Pmg Research Of Salisbury
mi
from
Salisbury, NC
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Pmg Research Of Salisbury
mi
from
Salisbury, NC
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
PMG Research of Winston-Salem
mi
from
Winston-Salem, NC
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
PMG Research of Winston-Salem
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Consultants for Clinical Research Inc.
mi
from
Cincinnati, OH
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Consultants for Clinical Research Inc.
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Ohio Gastroenterology and Liver
mi
from
Cincinnati, OH
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Ohio Gastroenterology and Liver
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Advanced Research Institute
mi
from
Ogden, UT
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Advanced Research Institute
mi
from
Ogden, UT
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
University of Utah
mi
from
Salt Lake City, UT
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
University of Washington Medical Center
mi
from
Seattle, WA
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
L-carnitine to Treat Fatigue Associated With Crohn's Disease
L-carnitine to Treat Fatigue Associated With Crohn's Disease
Status: Enrolling
Updated:  5/15/2013
UCSF Medical Center, Mt. Zion Medical Center
mi
from
San Francisco, CA
L-carnitine to Treat Fatigue Associated With Crohn's Disease
L-carnitine to Treat Fatigue Associated With Crohn's Disease
Status: Enrolling
Updated: 5/15/2013
UCSF Medical Center, Mt. Zion Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Glendale, AZ
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Glendale, AZ
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Anaheim, CA
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Aurora, CO
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Aurora, CO
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
New Haven, CT
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Jacksonville, FL
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Roswell, GA
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Roswell, GA
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Joliet, IL
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Joliet, IL
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Louisville, KY
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Louisville, KY
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Baton Rouge, LA
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Bethesda, MD
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Bethesda, MD
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Boston, MA
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Grand Rapids, MI
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Rochester, MN
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Rochester, MN
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Chesterfield, MO
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Chesterfield, MO
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
New York, NY
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Durham, NC
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Durham, NC
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Cincinnati, OH
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Weatherford, OK
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Weatherford, OK
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Klamath Falls, OR
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Klamath Falls, OR
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Philadelphia, PA
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Knoxville, TN
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Knoxville, TN
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Salt Lake City, UT
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Richmond, VA
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Richmond, VA
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Kennewick, WA
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Kennewick, WA
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
La Crosse, WI
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
La Crosse, WI
Click here to add this to my saved trials
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
Multi Center, Observational, Retrospective Data Collection of Patients Treated With the ColonRing in Routine Clinical Practice. This Study to Continue RETROPRESS Study ID NCT01301417
Status: Enrolling
Updated:  6/16/2013
Florida Hospital, Center for Colon & Rectal Surgery
mi
from
Atlamonte Springs, FL
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
Multi Center, Observational, Retrospective Data Collection of Patients Treated With the ColonRing in Routine Clinical Practice. This Study to Continue RETROPRESS Study ID NCT01301417
Status: Enrolling
Updated: 6/16/2013
Florida Hospital, Center for Colon & Rectal Surgery
mi
from
Atlamonte Springs, FL
Click here to add this to my saved trials
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
Multi Center, Observational, Retrospective Data Collection of Patients Treated With the ColonRing in Routine Clinical Practice. This Study to Continue RETROPRESS Study ID NCT01301417
Status: Enrolling
Updated:  6/16/2013
18308 Murdock Circle, Suite 108
mi
from
Port Charlotte, FL
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
Multi Center, Observational, Retrospective Data Collection of Patients Treated With the ColonRing in Routine Clinical Practice. This Study to Continue RETROPRESS Study ID NCT01301417
Status: Enrolling
Updated: 6/16/2013
18308 Murdock Circle, Suite 108
mi
from
Port Charlotte, FL
Click here to add this to my saved trials